DE69128664T2 - CNP-Gen und Vorläuferprotein aus Schwein - Google Patents

CNP-Gen und Vorläuferprotein aus Schwein

Info

Publication number
DE69128664T2
DE69128664T2 DE69128664T DE69128664T DE69128664T2 DE 69128664 T2 DE69128664 T2 DE 69128664T2 DE 69128664 T DE69128664 T DE 69128664T DE 69128664 T DE69128664 T DE 69128664T DE 69128664 T2 DE69128664 T2 DE 69128664T2
Authority
DE
Germany
Prior art keywords
leu
gly
lys
ala
pro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69128664T
Other languages
English (en)
Other versions
DE69128664D1 (de
Inventor
Hisayuki Matsuo
Kenji Kangawa
Naoto Minamino
Shoji Tanaka
Kayoko Kawashima
Yasunori Tawaragi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MATSUO, HISAYUKI, KOBE, HYOGO, JP
Asubio Pharma Co Ltd
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Application granted granted Critical
Publication of DE69128664D1 publication Critical patent/DE69128664D1/de
Publication of DE69128664T2 publication Critical patent/DE69128664T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DE69128664T 1990-07-13 1991-07-12 CNP-Gen und Vorläuferprotein aus Schwein Expired - Lifetime DE69128664T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2186583A JP3026351B2 (ja) 1990-07-13 1990-07-13 ブタｃｎｐ遺伝子及び前駆体蛋白

Publications (2)

Publication Number Publication Date
DE69128664D1 DE69128664D1 (de) 1998-02-19
DE69128664T2 true DE69128664T2 (de) 1998-06-04

Family

ID=16191085

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69128664T Expired - Lifetime DE69128664T2 (de) 1990-07-13 1991-07-12 CNP-Gen und Vorläuferprotein aus Schwein
DE69133591T Expired - Lifetime DE69133591T2 (de) 1990-07-13 1991-07-12 CNP-Gen und Vorläuferprotein aus Schwein

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69133591T Expired - Lifetime DE69133591T2 (de) 1990-07-13 1991-07-12 CNP-Gen und Vorläuferprotein aus Schwein

Country Status (8)

Country Link
US (1) US6020168A (de)
EP (2) EP0466175B1 (de)
JP (1) JP3026351B2 (de)
AT (2) ATE386118T1 (de)
DE (2) DE69128664T2 (de)
DK (1) DK0466175T3 (de)
ES (2) ES2303336T3 (de)
GR (1) GR3026553T3 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3026352B2 (ja) * 1990-09-11 2000-03-27 壽之 松尾 ラットＣＮＰｃＤＮＡ及び前駆体蛋白
AU3749293A (en) * 1992-03-18 1993-10-21 Wolf-Georg Forssmann DNA coding for aphrodisin
IL142118A0 (en) * 2001-03-20 2002-03-10 Prochon Biotech Ltd Method and composition for treatment of skeletal dysplasias
AU2005235635B2 (en) 2004-04-21 2010-11-18 Alexion Pharmaceuticals, Inc. Bone delivery conjugates and method of using same to target proteins to bone
EP2217620A2 (de) 2007-11-21 2010-08-18 BioMarin Pharmaceutical Inc. Varianten des natriuretischen peptids typ c
KR102033680B1 (ko) 2009-05-20 2019-10-18 바이오마린 파머수티컬 인크. 씨형 나트륨이뇨 펩티드의 변이체
AU2011350066A1 (en) 2010-12-27 2013-07-11 Alexion Pharma International Sarl Compositions comprising natriuretic peptides and methods of use thereof
WO2013058833A1 (en) 2011-10-19 2013-04-25 Enobia Canada Limited Partnership Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
WO2013095759A1 (en) * 2011-12-23 2013-06-27 Mayo Foundation For Medical Education And Research Assessing renal structural alterations and outcomes
US10052366B2 (en) 2012-05-21 2018-08-21 Alexion Pharmaceuticsl, Inc. Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
US10822596B2 (en) 2014-07-11 2020-11-03 Alexion Pharmaceuticals, Inc. Compositions and methods for treating craniosynostosis
KR20170095278A (ko) 2014-12-05 2017-08-22 알렉시온 파마슈티칼스, 인코포레이티드 재조합 알칼리성 포스파타제를 이용한 발작 치료
AU2016211447B2 (en) 2015-01-28 2021-09-23 Alexion Pharmaceuticals, Inc. Methods of treating a subject with an alkaline phosphatase deficiency
CN107532196B (zh) * 2015-03-30 2021-07-27 国立大学法人神户大学 动物物种的鉴定方法
WO2017031114A1 (en) 2015-08-17 2017-02-23 Alexion Pharmaceuticals, Inc. Manufacturing of alkaline phosphatases
WO2017058822A1 (en) 2015-09-28 2017-04-06 Alexion Pharmaceuticals, Inc. Identifying effective dosage regimens for tissue non-specific alkaline phosphatase (tnsalp)-enzyme replacement therapy of hypophosphatasia
WO2017074466A1 (en) 2015-10-30 2017-05-04 Alexion Pharmaceuticals, Inc. Methods for treating craniosynostosis in a patient
US11065306B2 (en) 2016-03-08 2021-07-20 Alexion Pharmaceuticals, Inc. Methods for treating hypophosphatasia in children
WO2017173395A1 (en) 2016-04-01 2017-10-05 Alexion Pharmaceuticals, Inc. Methods for treating hypophosphatasia in adolescents and adults
US11186832B2 (en) 2016-04-01 2021-11-30 Alexion Pharmaceuticals, Inc. Treating muscle weakness with alkaline phosphatases
WO2017214130A1 (en) 2016-06-06 2017-12-14 Alexion Pharmaceuticals, Inc. Metal impact on manufacturing of alkaline phosphatases
JP7018933B2 (ja) 2016-08-18 2022-02-14 アレクシオン ファーマシューティカルズ， インコーポレイテッド 気管気管支軟化症の治療方法
CN110719786A (zh) 2017-03-31 2020-01-21 阿雷克森制药公司 用于治疗成人和青少年的低磷酸酯酶症(hpp)的方法
WO2019190752A1 (en) 2018-03-30 2019-10-03 Alexion Pharmaceuticals, Inc. Manufacturing of glycoproteins

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60136596A (ja) 1983-12-26 1985-07-20 Suntory Ltd ペプチド及びこれを有効成分とする利尿剤
JPS60184098A (ja) 1984-03-02 1985-09-19 Suntory Ltd 新規なペプチド及びこれを有効成分とする利尿剤
JPH0794473B2 (ja) 1984-03-02 1995-10-11 サントリー株式会社 新規なペプチド及びこれを有効成分とする利尿剤
JPS60260596A (ja) 1984-06-08 1985-12-23 Toshiyuki Matsuo 新規なペプチド及びこれを有効成分とする医薬
JPS617298A (ja) 1984-06-22 1986-01-13 Toshiyuki Matsuo 新規なペプチド及びこれを有効成分とする医薬

Also Published As

Publication number Publication date
JP3026351B2 (ja) 2000-03-27
EP0466175A1 (de) 1992-01-15
DK0466175T3 (da) 1998-09-07
EP0466175B1 (de) 1998-01-14
US6020168A (en) 2000-02-01
ES2112258T3 (es) 1998-04-01
JPH0474199A (ja) 1992-03-09
ATE386118T1 (de) 2008-03-15
DE69133591D1 (de) 2008-03-27
DE69128664D1 (de) 1998-02-19
EP0771875A1 (de) 1997-05-07
ES2303336T3 (es) 2008-08-01
ATE162201T1 (de) 1998-01-15
EP0771875B1 (de) 2008-02-13
GR3026553T3 (en) 1998-07-31
DE69133591T2 (de) 2009-02-05

Similar Documents

Publication Publication Date Title
DE69128664D1 (de) CNP-Gen und Vorläuferprotein aus Schwein
NL300013I1 (nl) Nieuwe protein met TNF-remmende werking en hun ber
HK1154211A1 (zh) 預防和減少失血和炎症反應
MD1652F2 (en) Protein possessing the cytokin - type activity, recombinant DNA-codifyer for such protein, transformed cells and microorganism, expression vector, process for protein obtaining and remedy containing such a protein
NO942553D0 (no) Ny humanproteaseinhibitor av Kunitz-type og varianter derav
DE3486154D1 (de) Cardiodilatin, ein neues peptidhormon und verfahren zu seiner herstellung.
DE69126487T2 (de) cDNA für Ratten C-Typ natriuretisches Peptid und Vorläuferprotein
YU29596A (sh) Genski proizvodi koji regulišu gojaznost
CA2002924A1 (en) Anti-Thrombins
DE69201438D1 (en) Als therapeutika geeignete peptide.
EP0292257A3 (de) Peptide mit ANF-Wirksamkeit
DE3751398T2 (de) Substrat-Peptide.
EP0687685A4 (de) Physiologisch-aktive peptide
ES8605987A1 (es) Procedimiento para preparar polipeptidos inmunoterapeuticos
IT1177963B (it) Agenti polipeptidici immunoterapeutici e procedimento di preparazione

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: DAIICHI SUNTORY PHARMA CO., LTD., TOKIO/TOKYO, JP

Owner name: MATSUO, HISAYUKI, KOBE, HYOGO, JP

8327 Change in the person/name/address of the patent owner

Owner name: DAIICHI ASUBIO PHARMA CO., LTD., TOKIO/TOKYO, JP

Owner name: MATSUO, HISAYUKI, KOBE, HYOGO, JP

8327 Change in the person/name/address of the patent owner

Owner name: ASUBIO PHARMA CO., LTD., TOKYO, JP

Owner name: MATSUO, HISAYUKI, KOBE, HYOGO, JP